[Recent advances on EZH2 in malignant tumors]
- PMID: 20193471
[Recent advances on EZH2 in malignant tumors]
Similar articles
-
The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer.J Mol Histol. 2006 Sep;37(5-7):219-23. doi: 10.1007/s10735-006-9042-9. Epub 2006 Jul 20. J Mol Histol. 2006. PMID: 16855786 Review.
-
Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8570-6. doi: 10.1158/1078-0432.CCR-05-1047. Clin Cancer Res. 2005. PMID: 16361539
-
Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.Cancer. 2010 Jun 15;116(12):3015-24. doi: 10.1002/cncr.25128. Cancer. 2010. PMID: 20564407
-
High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.Oral Oncol. 2009 Jan;45(1):39-46. doi: 10.1016/j.oraloncology.2008.03.016. Epub 2008 Jul 10. Oral Oncol. 2009. PMID: 18619895
-
Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements.J Cell Physiol. 2008 Feb;214(2):295-300. doi: 10.1002/jcp.21241. J Cell Physiol. 2008. PMID: 17786943 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical